Oscar Health, Inc. (NYSE:OSCR - Get Free Report)'s share price gapped up prior to trading on Thursday . The stock had previously closed at $16.62, but opened at $17.36. Oscar Health shares last traded at $16.36, with a volume of 10,540,126 shares changing hands.
Wall Street Analyst Weigh In
OSCR has been the topic of a number of recent analyst reports. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Piper Sandler dropped their target price on shares of Oscar Health from $25.00 to $18.00 and set an "overweight" rating for the company in a report on Monday, June 9th. Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Finally, Barclays initiated coverage on Oscar Health in a report on Wednesday. They issued an "underweight" rating and a $17.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $16.58.
Check Out Our Latest Report on Oscar Health
Oscar Health Stock Performance
The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88. The stock has a fifty day simple moving average of $15.84 and a two-hundred day simple moving average of $14.76. The stock has a market cap of $4.21 billion, a PE ratio of 59.00 and a beta of 1.90.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same period in the prior year, the firm earned $0.62 earnings per share. The business's quarterly revenue was up 42.2% compared to the same quarter last year. Equities analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
Insider Activity
In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director owned 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 24.39% of the company's stock.
Institutional Investors Weigh In On Oscar Health
Several hedge funds and other institutional investors have recently bought and sold shares of OSCR. Rhumbline Advisers grew its holdings in Oscar Health by 6.0% during the 1st quarter. Rhumbline Advisers now owns 287,458 shares of the company's stock worth $3,769,000 after acquiring an additional 16,231 shares in the last quarter. Strs Ohio bought a new position in shares of Oscar Health during the first quarter worth about $30,000. Intech Investment Management LLC lifted its position in shares of Oscar Health by 50.3% during the first quarter. Intech Investment Management LLC now owns 139,600 shares of the company's stock worth $1,830,000 after purchasing an additional 46,748 shares during the last quarter. Focus Partners Wealth grew its stake in Oscar Health by 1.8% in the first quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock worth $723,000 after purchasing an additional 949 shares in the last quarter. Finally, SCS Capital Management LLC bought a new stake in Oscar Health in the first quarter valued at about $131,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
